Staar Surgical Co (STAA) Stock Price

STAAStock

$22.11−19.31%52W

Market Cap$1.11B

P/E—

PEG Ratio0.76

Div yield—

Beta1.18

STAA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)0.02%

Price vs S&P 500 (4W)-10.70%

PEG Ratio0.76

VGM Score40.77

P/CF (Annual)57.84x

Book Value / Share (Quarterly)$7.08

P/TBV (Annual)3.74x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-5.57%

Cash Flow / Share (Quarterly)$-1.10

Price vs S&P 500 (YTD)-17.07%

Gross Margin (TTM)76.89%

Net Profit Margin (TTM)-7.24%

EPS (TTM)$-0.43

10-Day Avg Trading Volume0.75M

EPS Excl Extra (TTM)$-0.43

Revenue Growth (5Y)7.93%

EPS (Annual)$-1.62

ROI (Annual)-23.37%

Gross Margin (Annual)76.19%

Net Profit Margin (5Y Avg)-1.83%

Cash / Share (Quarterly)$3.29

Revenue Growth QoQ (YoY)119.59%

ROA (Last FY)-17.81%

Revenue Growth TTM (YoY)4.03%

EBITD / Share (TTM)$-0.36

ROE (5Y Avg)-0.36%

Operating Margin (TTM)-9.07%

Cash Flow / Share (Annual)$-0.81

P/B Ratio3.59x

P/B Ratio (Quarterly)2.84x

Net Income / Employee (Annual)$-84,100

EV / Revenue (TTM)3.90x

Net Interest Coverage (TTM)11.43x

ROA (TTM)-4.68%

EPS Growth QoQ (YoY)-12.41%

EV / EBITDA (TTM)35.87x

EPS Incl Extra (Annual)$-1.62

Current Ratio (Annual)4.55x

Quick Ratio (Quarterly)4.11x

3-Month Avg Trading Volume0.89M

52-Week Price Return-19.31%

EV / Free Cash Flow (Annual)57.39x

Revenue / Employee (TTM)$303,400

Tangible BV / Share (Quarterly)$6.39

P/S Ratio (Annual)5.28x

Asset Turnover (Annual)0.53x

52-Week High$35.87

Operating Margin (5Y Avg)-0.75%

EPS Excl Extra (Annual)$-1.62

CapEx CAGR (5Y)-7.08%

Tangible BV CAGR (5Y)14.46%

26-Week Price Return11.95%

Quick Ratio (Annual)3.54x

13-Week Price Return-23.97%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)5.12x

Enterprise Value$1.13B

Revenue / Share Growth (5Y)7.24%

Asset Turnover (TTM)0.65x

Book Value / Share Growth (5Y)10.39%

Revenue / Employee (Annual)$250,200

Inventory Turnover (Annual)1.90x

Pretax Margin (Annual)-34.36%

Cash / Share (Annual)$3.80

3-Month Return Std Dev53.16%

Gross Margin (5Y Avg)77.38%

Net Income / Employee (TTM)$-22,000

EBITDA Interim CAGR (5Y)3.87%

ROE (Last FY)-23.37%

Net Interest Coverage (Annual)106.09x

EPS Basic Excl Extra (Annual)$-1.62

P/FCF (TTM)709.15x

Receivables Turnover (TTM)4.79x

EV / Free Cash Flow (TTM)261.09x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.43

Receivables Turnover (Annual)3.64x

ROI (TTM)-6.07%

P/S Ratio (TTM)4.36x

Pretax Margin (5Y Avg)0.56%

Revenue / Share (Annual)$4.83

Tangible BV / Share (Annual)$6.35

Forward P/E53.02x

Price vs S&P 500 (52W)-37.87%

Year-to-Date Return-4.24%

5-Day Price Return-4.94%

EPS Normalized (Annual)$-1.62

ROA (5Y Avg)-0.19%

Net Profit Margin (Annual)-33.60%

Month-to-Date Return-9.24%

Cash Flow / Share (TTM)$0.50

EBITD / Share (Annual)$-1.75

Operating Margin (Annual)-38.30%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-0.36%

LT Debt / Equity (Quarterly)0.15x

EPS Basic Excl Extra (TTM)$-0.43

P/TBV (Quarterly)3.15x

P/B Ratio (Annual)3.41x

Inventory Turnover (TTM)1.37x

Pretax Margin (TTM)-6.74%

Book Value / Share (Annual)$6.97

Price vs S&P 500 (13W)-25.92%

Beta1.18x

P/FCF (Annual)71.84x

Revenue / Share (TTM)$5.70

ROE (TTM)-6.07%

52-Week Low$15.59

vGradeD

gGradeC

mGradeD

vgmGradeC

STAA Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 12, 2026	$0.23	$0.25	+9.71%(+$0.02)
Q1 2026	May 13, 2026	$0.08	$0.29	+266.75%(+$0.21)
Q4 2025	Mar 3, 2026	$0.17	$0.01	-95.19%(-$0.16)
Q3 2025	Nov 5, 2025	$0.28	$0.47	+68.34%(+$0.19)
Q2 2025	Aug 6, 2025	-$0.56	-$0.13	+77.02%(+$0.43)

STAA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.53

3.65

3.56

Industry Peers — Ophthalmic Goods(8)

Symbol	Value Score	Growth Score	Momentum Score	Price
STAAStaar Surgical Co	D	C	D	$22.11
ALCAlcon Inc. Ordinary Shares	C	C	C	$72.01
COOThe Cooper Companies, Inc. Common Stock	C	C	C	$71.17
BLCOBausch + Lomb Corporation	B	C	B	$17.15
WRBYWarby Parker Inc.	D	B	C	$25.00
EYENational Vision Holdings, Inc. Common Stock	B	D	D	$17.38
RXSTRxSight, Inc. Common Stock	B	C	B	$7.05
LUCYInnovative Eyewear, Inc. Common Stock	B	A	D	$0.95
LUCYWInnovative Eyewear, Inc. Series A Warrants 8/16/27	—	—	F	$0.04

About Staar Surgical Co

STAAR Surgical Co manufactures Implantable Collamer Lenses (ICL) and delivery systems for refractive eye surgery. The company derives nearly all revenue from ICL sales, which are used to correct myopia and other refractive errors. A substantial portion of revenues comes from international markets.